College of Contemporary Health

18/11/2025

Researchers, clinicians and scientists at Stanford University have developed a model designed to improve prediction accuracy around donor viability.

The tool estimates whether a donor is likely to die within the period during which their organs remain suitable for transplantation.

The model surpassed the predictions of highly experienced surgeons and reduced the rate of futile procurements by 60%.

Futile procurements occur when surgical teams begin preparing for a but cannot proceed because the donor dies too late for the organ to remain viable.

A Stanford-developed AI tool predicts whether donor organs will remain viable within critical time limits, cutting futile transplant attempts by 60 percent and improving access for people awaiting transplants.

17/11/2025

Can you answer these three questions about AI in general practice?

→ Which AI tools actually save time versus adding work to your day?
→ How do you evaluate if an AI system meets NHS standards?
→ What happens to accountability when AI gets it wrong?

Most GPs can’t answer these confidently. Not because they’re unprepared, but because they’ve never been trained.

CCH have just launched 𝐀𝐈 𝐄𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥𝐬 𝐟𝐨𝐫 𝐆𝐏𝐬: 𝐓𝐨𝐨𝐥𝐬, 𝐄𝐭𝐡𝐢𝐜𝐬 𝐚𝐧𝐝 𝐄𝐯𝐞𝐫𝐲𝐝𝐚𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐢𝐭𝐨𝐧𝐬 - a CPD course that addresses exactly these questions.

Covers: AI tool evaluation, NHS standards, professional accountability, practical implementation.

Immediately applicable. 3.5 hours. £39.00 (launch price)

➡️ Course details here: https://www.contemporaryhealth.co.uk/ai-essentials-for-gps/

17/11/2025

A new report from the healthcare advisory firm Chartis suggests that and are now central pillars in health system leaders’ strategies to expand capacity, improve access, and operate more sustainably.

The findings come from the firm’s fifth annual survey, conducted in September 2025, which examined the perspectives of 150 system executives on their progress and priorities in transformation.

A new Chartis survey of 150 health system executives reveals that leaders are prioritising AI and digital health solutions to expand capacity, improve access, and shift towards proactive models of care. Findings highlight the growing importance of hospital-at-home services, digitally enabled referra...

14/11/2025

For many clinicians, the administrative workload associated with electronic health record ( ) systems extends well into the evening, contributing to frustration, diminished work satisfaction and widespread .

At Sutter Health in California, leaders have undertaken a substantial effort to determine whether augmented intelligence ( ) could help relieve this pressure and restore time and attention to patient care.

A recent pilot study, published in JAMA Network Open, involved physicians and non-physician providers across the organisation.

Participants reported spending less time on after-hours notes, feeling more present with patients during consultations and experiencing early signs of reduced .

Although limitations remain, the findings suggest that carefully implemented AI-supported documentation could contribute meaningfully to clinician well-being.

A Sutter Health study shows ambient AI reduced after-hours documentation, eased cognitive burden and helped 93% of clinicians give patients their “full attention”.

13/11/2025

A co-designed, digitally supported recovery pathway is helping people in regional access surgeon-approved post-operative without the need for long-distance travel.

The Panacea Pathway integrates predictive analytics and -generated insights to monitor progress, identify risks early, and support safer and more consistent recovery at home.

More than 3,000 at-home clinical appointments have been delivered, with patients reporting greater confidence, improved continuity of care, and fewer missed appointments.

A new AI-supported telehealth pathway is transforming hip replacement recovery for regional Australians by enabling safe, at-home monitoring and personalised care.

12/11/2025

People with (AFib) and may experience fewer episodes of irregular heart rhythm after undergoing ablation if they take the diabetes medication in addition to standard care, according to a preliminary presentation of late-breaking science at the American Heart Association’s (AHA) Scientific Sessions 2025, held from 7 to 10 November in New Orleans.

The annual meeting is a leading international forum for sharing new research and clinical advances in .

A new study presented at the American Heart Association’s 2025 Scientific Sessions found that metformin may help prevent atrial fibrillation recurrence after ablation in adults with obesity, suggesting potential cardiovascular benefits beyond diabetes management.

11/11/2025

Investigators at Weill Cornell Medicine have uncovered an early step in the chain of events that links to inflammation and insulin resistance – key contributors to the development of type 2 .

Their findings, published on 28 October in the The Journal of Clinical Investigation family of journals, identify a protein known as FAM20C as a critical “switch” that initiates within fat cells.

The study, conducted in mice, shows that when this protein is removed or blocked, improves markedly, even without weight loss.

Researchers at Weill Cornell Medicine have identified FAM20C, a protein that triggers inflammation and insulin resistance in fat cells. Blocking FAM20C improved metabolic health and insulin sensitivity in mice, revealing a promising new target for treating obesity-related type 2 diabetes.

10/11/2025

Researchers at Virginia Tech found that resistance training was more effective than running in improving glucose tolerance and reducing insulin resistance in mice fed a high-fat diet.

Both endurance and resistance reduced body fat and improved blood sugar regulation, but resistance training yielded stronger metabolic benefits.

The study suggests that strength training could play a particularly valuable role in preventing and managing Type 2 .

A new study from Virginia Tech shows that weightlifting is more effective than running in reducing fat, improving glucose tolerance, and lowering insulin resistance in a preclinical model of obesity and Type 2 diabetes.

06/11/2025

Novo Nordisk has presented new findings suggesting that its experimental oral medication delivers cardiovascular and metabolic benefits similar to those achieved with its blockbuster injectable, .

The results were shared at the ObesityWeek 2025 conference in and strengthen the Danish company’s case for approval of the pill in the United States later this year.

Novo Nordisk’s oral semaglutide 25 mg pill matches Wegovy injection for weight loss and cardiovascular benefits, new OASIS 4 data reveal.

05/11/2025

Newly released data from the National Child Measurement Programme ( ) show that 10.5% of children aged four to five (Reception year) in are living with obesity – the highest prevalence recorded outside of the pandemic period.

The NCMP, which annually measures the height and weight of primary school pupils, also found that more than one in five pupils in Year 6 (aged 10–11) are living with . The findings indicate that boys are more likely to be overweight or have obesity than girls.

In Reception year, 13% of children were classified as overweight, meaning that almost one in four children in this age group are either or living with obesity.

Excluding the sharp increase seen during the first year of the COVID-19 pandemic, these figures represent the highest obesity prevalence in Reception year since records began in 2006–07 and mark a rise from 9.6% in 2023–24.

New data from the National Child Measurement Programme show that one in ten children aged four to five in England are living with obesity – the highest level recorded outside the pandemic. Teachers warn that cuts to school sport, rising poverty, and food insecurity are fuelling the crisis, as many...

04/11/2025

Up to 5,000 adults living with obesity in ’s most deprived areas will receive free weight-loss injections through the new Scotland CardioMetabolic Impact Study (SCoMIS).

The multi-million-pound research, led by the University of Glasgow, aims to test the real-world delivery and impact of incretin-based therapies in care.

The study seeks to reduce health inequalities, improve quality of life, and lessen the long-term burden of on individuals and the NHS.

Up to 5,000 adults in Scotland’s most deprived areas will receive free weight-loss injections through a landmark University of Glasgow-led study. The SCoMIS trial aims to reduce obesity and health inequalities through equitable access to incretin-based therapies.

31/10/2025

A new randomised controlled trial published in Antioxidants MDPI has found that consuming freeze-dried strawberries (FDS) daily may help reduce fasting blood glucose and vascular inflammation in adults with .

The research also showed marked improvements in status, highlighting the potential of strawberries as a simple dietary intervention for .

The authors concluded that “strawberries may represent a practical dietary intervention that improves fasting glucose and strengthens antioxidant defence in adults with .”

A 12-week trial has found that daily consumption of freeze-dried strawberries improves fasting glucose, reduces inflammation, and boosts antioxidant defences in adults with prediabetes.